.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
A recent meta-analysis provides evidence for using endovascular treatment in stroke patients with pre-existing disabilities. Traditionally, clinical trials often exclude patients with a baseline modified Rankin Scale (mRS) score of 2 or higher. However, researchers suggest that withholding therapy based on prior disability might deny patients significant clinical benefits. Specifically, this group often suffers from limited treatment options during acute events.
The meta-analysis evaluated data from five studies including 1,400 patients. Additionally, researchers compared endovascular thrombectomy (EVT) with best medical treatment. Consequently, the results showed that EVT significantly reduced all-cause mortality. Furthermore, patients receiving endovascular intervention were more likely to return to their baseline functional status. Specifically, the odds of returning to pre-stroke mRS were over three times higher. Moreover, safety remains a primary concern for clinicians. Despite this, the study found no significant increase in symptomatic intracranial hemorrhage. Therefore, the safety profile appears favorable in those with moderate pre-existing disability. As a result, these findings encourage clinicians to evaluate each case individually rather than following rigid exclusion criteria.
Yes, the meta-analysis found that endovascular treatment significantly reduces all-cause mortality in patients with pre-stroke disabilities compared to medical therapy alone.
No, the study indicated that there was no statistically significant difference in the rates of symptomatic intracranial hemorrhage between patients receiving EVT and those on medical treatment.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Meta-analysis shows EVT reduces mortality and improves recovery in acute ischemic stroke patients with pre-existing disabilities (mRS ≥ 2)....
6 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
